Last reviewed · How we verify

Trichosanthes root

China Medical University Hospital · FDA-approved active Small molecule

Trichosanthes root contains bioactive compounds that exhibit anti-inflammatory, immunomodulatory, and potential antitumor properties through multiple cellular pathways.

Trichosanthes root contains bioactive compounds that exhibit anti-inflammatory, immunomodulatory, and potential antitumor properties through multiple cellular pathways. Used for Cancer (various types, traditional use in Chinese medicine), Inflammatory conditions.

At a glance

Generic nameTrichosanthes root
SponsorChina Medical University Hospital
ModalitySmall molecule
Therapeutic areaOncology
PhaseFDA-approved

Mechanism of action

Trichosanthes root (from the plant Trichosanthes kirilowii) is a traditional Chinese medicine ingredient containing proteins, polysaccharides, and other phytochemicals that modulate immune function and inflammatory responses. Preclinical studies suggest it may inhibit tumor cell proliferation and induce apoptosis, though the exact molecular mechanisms remain incompletely characterized in clinical settings.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: